Christopher U. Missling, President and CEO at ANAVEX LIFE SCIENCES CORP. (AVXL), bought 750 shares at $4.22 ($3K) on 2017-10-13, disclosed to the SEC on 2017-10-16.
Scheduled purchase ($3k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVXL | SELL | 2021-07-01 | $1.3M | — | Filing → |
| AVXL | BUY | 2018-03-09 | $4K | — | Filing → |
| AVXL | BUY | 2018-03-07 | $4K | — | Filing → |